Improved culture methods to expand schwann cells with altered growth behaviour from CMT1a patients

GLIA

Volumn 23, Issue 2, 1998, Pages 89-98

  Hanemann, C Oliver ^a   Rosenbaum, Claudia ^a   Kupfer, Sandra ^a   Wosch, Susanne ^a   Stoegbauer, Florian ^b   Müller, Hans Werner ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cell culture; Charcot Marie disease; Human Schwann cells; PMP22; Proliferation

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; MYELIN PROTEIN; PMP22 PROTEIN, HUMAN; PMP22 PROTEIN, RAT;

ARTICLE; CELL DIVISION; CULTURE TECHNIQUE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; SCHWANN CELL;

ANTIGENS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIVISION; CHARCOT-MARIE-TOOTH DISEASE; HUMANS; MYELIN PROTEINS; SCHWANN CELLS;

EID: 0032104866     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199806)23:2<89::AID-GLIA1>3.0.CO;2-Z     Document Type: Article

References (42)

1. Askansas, V., King Engel, W., Dalakas, M.C., Lawrence, J.V., and Carter, L.S. (1980) Human Schwann cells in tissue culture. Histochemical and ultrastructural studies. Arch. Neurol., 37:329-337.
2. Baechner, D., Liehr, T., Hameister, H., Altenberger, H., Grehl, H., Suter, U., and Rautenstrauss, B. (1995) Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development. J. Neurosci. Res., 42:733-741.
3. Bartsch, U., Kirchhoff, F., and Schachner, M. (1989) Immunohistological localisation of the adhesion molecules L1, N-CAM, and MAG in the developing and adult optic nerve of mice. J. Comp. Neurol., 284:451-462.
4. Bollensen, E., Scheidt, P., Schachner, M. (1990) Production and characterisation of monoclonal antibodies to the major peripheral mylein protein P0. J. Neurochem., 54:1110-1114.
5. Bosse, F., Zoidl, G., Wilms, S., Gillen, C.P., Kuhn, H.G., and Müller, H.W. (1994) Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J. Neurosci. Res., 37:529-537.
6. Bottenstein, J. and Sato, G.H. (1979) Growth of a neuroblastoma cell line in serum free supplemented medium. Proc. Nat. Acad. Sci. USA, 76:514-517.
7. Casella, G.T.B., Bunge, R.P., and Wood, P.M. (1996) Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro. Glia, 17:327-338.
8. 0. Neuron, 16:309-319.
9. Chomczynski, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidiniumthiocyanate phenol chloroform extraction. Anal. Biochem., 162:156-159.
10. Church, G.M. and Gilbert, W. (1987) Genomic sequencing. Proc. Natl. Acad. Sci., 81:1991-1995.
11. Fabretti, E., Edomi, P., Brancolini, C., and Schneider, C. (1995) Apoptotic phenotype induced by overexpression of wild type gas3/ PM22: Its relation to the demyelinating peripheral neuropathy CMT1A. Genes and Development, 9:1846-1856.
12. Fischbeck, K.H. (1993) Charcot-Marie-Tooth disease type 1A, 9 Nov 92, San Francisco, CA, USA. Neuromusc. Dis., 3(1):81-82.
13. Gabreëls-Festen, A.A.W.M., Bolhuis, P.A., Hoogendijk, J.E., Valentijn, L.J., Eshuis, E.J.H.M., and Gabreëls, F.J.M. (1995) Charcot-MarieTooth disease type 1a: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol., 90:645-649.
14. Gennarini, G., Rougon, G., Deagostini-Bazan, H., Hirn, M., and Goridis, C. (1994) Studies on transmembrane disposition of the neuronal cell adhesion molecule N-CAM. Eur. J. Biochem., 142: 57-64.
15. Hanemann, C.O., Stoll, G., D'Urso, D., Fricke, W., Martin, J.J., Van Broeckhoven, C., Mancardi, G.L., Bartke, I., and Müller, H.W. (1994) Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1A sural nerve biopsies. J. Neurosci. Res., 37:654-659.
16. Hanemann, C.O., Stoll, G., and Müller, H.W. (1995) PMP22 expression in CMT1A neuropathy. Ann. Neurol., 37(1):136.
17. Hanemann, C.O., Gabreëls-Festen, A.A.W.M., Stoll, G., and Müller, H.W. (1996) Low affinity NGF-R expression in CMT1A nerve biopsies. Brain, 119:1461-1469.
18. Jessen, K.R. and Mirsky, R. (1991) Schwann cell precursors and their development. Glia, 4:185-194.
19. 0 during de novo myelination and nerve repair. Glia, 8:256-264.
20. Lemke, G. (1993) The molecular genetics of myelination: an update. Glia, 7:263-271.
21. Levi, A.D.O., Bunge, R.P., Lofgren, J.A., Meima, L., Hefti, F., Nikolics, K., and Sliwkowski, M.J. (1995) The influence of heregulins on human Schwann cell proliferation. J. Neurosci., 15:1329-1340.
22. Li, R-h., Chian, J., Hammonds, G., Phillips, H., Armanini, M., Wood, P., Bunge, R., Godowski, P.J., Sliwkowski, M.X., and Mather, J.P. (1996) Identification of Gas 6 as a growth factor for human Schwann cells. J. Neurosci., 16:2012-2019.
23. Lindl, T. and Bauer, J. (1989) Zell- und Gewebekultur, Gustav-Fischer Verlag Stuttgart 1989:63.
24. Magyar, J.P., Martini, R., Ruelicke, T., Aguzzi, A., Aldkofer, K., Dembic, Z., Ziaslek, J., Toyka, K., and Suter, U. (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci., 16(17):5351-5360.
25. Manfioletti, G., Ruaro, M.E., Del Sal, G., Phlipipson, L., and Schneider, C. (1990) A growth arrest-specific (gas) gene codes for a membrane protein. Mol. Cell. Biol., 10:2924-2930.
26. Morgan, L., Jessen, K.R., and Mirsky, R. (1991) The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (O4+) to a myelin phenotype (P0+, GFAP-, NCAM-, NGF-receptor-) depend on growth inhibition. J. Cell. Biol., 112(3): 457-467.
27. Morrissey, T.K., Bunge, R.P., and Kleitman, N (1995) Human Schwann cells in vitro. I: Failure to differentiate and support neuronal health under co-culture conditions that promote full function of rodent cells. J. Neurobiol., 28(2):171-189.
28. Nelis, E., Van Broeckhoven, C., and co authors. (1996) Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 (CMT1) and hereditary neuropathy with liability to pressure palsies (HNPP): a European collaborative study. Eur. J. Hum. Genet., 4:25-33.
29. Roa, B.B., Garcia, C.A., Suter, U., Kulpa, D.A., Wise, C.A., Mueller, J., Welcher, A.A., Snipes, G.J., Shooter, E.M., Patel, P.I., and Lupski, J.R. (1993) Charcot-Marie-Tooth disease tyoe 1A: Association with a spontaneous point muttaion in the PMP22 gene. New Eng. J. Med., 329(2):96-101.
30. Rutkowski, J.L., Tennekoon, G.I., and McGillicuddy, J.E. (1992) Selective culture of mitotically active human Schwann cells from adult sural nerves. Ann. Neurol., 31:580-586.
31. Rutkowski, J.L., Kirk, C.J., Lerner, M.A., and Tennekoon, G.I. (1995) Purification and expansion of human Schwann cells in vitro. Nature Med., 1:80-83.
32. Scarpini, E., Meola, G., Baron, P., Beretta, S., Velicogna, M., and Scralato, G. (1986) S-100 protein and laminin: Immunocytochemical markers for human Schwann cells in vitro. Exp. Neurol., 93:77-83.
33. Schumacher, M., Jung-Testas, I., Robel, P., and Baulieu, E.-E. (1993) Insulin-like growth factor I: A mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP. GLIA, 8:232-240.
34. Sereda, M., Griffiths, I., Pühlhofer, A., Stewart, H., Rossenr, M.J., Zimmermann, F., Magyar, J.P., Schneider, A., Hunde, E., Meinck, H.-J., Suter, U., and Nave, K. (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron, 16:1049-1060.
35. Skre, H. (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet., 6:98-118.
36. Snipes, G.J., Suter, U., Welcher, A.A., and Shooter, E.M. (1992) Characterisation of a novel peripheral nervous system myelin protein (PMP22/SR13). J. Cell Biol., 117(1):225-238.
37. Spreyer, P., Kuhn, G., Hanemann, C.O., Gillen, C., Schaal, H., Kuhn, R., Lemke, G.E., and Müller, H.W. (1991) Axon regulated expression of a Schwann cell mRNA that is homologous to a growth arrest specific gene. EMBO J., 10:3661-3668.
38. Stewart, H.S., Bradke, F., Tabernero, A., Morell, D., Jessen, K.R., and Mirsky, R. (1996) Regulation of rat Schwann cell P0 expression and DNA synthesis by insulin-like growth factors in vitro. Eur. J. Neurosci., 8:553-564.
39. Suter, U., Snipes, G.J., Schoener-Scott, R., Welcher, A.W., Pareek, S., Lupski, J.R., Murphy, R.A., Shooter, E.M., and Patel, P.I. (1994) Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem., 269:25795-25808.
40. Yoshikawa, H., Nishimura, T., Nkattsuji, Y., Fujimura, H., Himoro, M., Hayaska, K., Sakoda, S., and Yanagihara, T. (1994) Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann. Neurol., 35:445-450.
41. Valentijn, L.J., Baas, F., Wolterman, R.A., Hoogendijk, J.E., van den Bosch, N.H.A., Zorn, I., Gabreëls-Festen, A.A.W.M., de Visser, M., and Bolhuis, P.A. (1992) Identical point mutation of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Gen., 2:288-291.
42. Zoidl, G., Blass-Kampmann, S., D'Urso, D., Schmalenbach, C., and Müller, H.W. (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J., 14(6):1122-1128.